TY - JOUR
T1 - Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis
AU - Singh, Nina
AU - Suarez, Jose F.
AU - Avery, Robin
AU - Lass-Flörl, Cornelia
AU - Geltner, Christian
AU - Pasqualotto, Alessandro C.
AU - Marshall Lyon, G.
AU - Barron, Michelle
AU - Husain, Shahid
AU - Wagener, Marilyn M.
AU - Montoya, Jose G.
N1 - Funding Information:
The study was supported in part by Pfizer Inc . However, the sponsor had no role in study design, conduct, analyses and interpretation of results.
PY - 2013/7
Y1 - 2013/7
N2 - Background: Whether nodular lesions have specific risk-factors or influence outcomes in lung transplant recipients with invasive aspergillosis, is not fully known. Methods: The study population consisted of 64 consecutive lung transplant recipients with proven or probable invasive aspergillosis. Nodules, with or without halo/air crescent-sign were considered nodular presentations. Outcomes assessed were response rate (successful versus unsuccessful outcome) and all-cause mortality at 12 weeks. Results: Overall, 34 patients had nodular and 30 had non-nodular lesions. Presence of nodular lesions was less likely to be associated with renal failure at baseline (adjusted OR 0.21, 95% CI, 0.04-0.97, p=0.047), CMV infection (adjusted OR 0.18, 95% CI 0.04-0.75, p=0.019) and receipt of antifungal prophylaxis (adjusted OR 0.22, 95% CI, 0.06-0.88, p=0.032). Successful outcome and mortality rates in the study patients were 64.0% (41/64) and 25.0% (16/64), respectively. Nodular aspergillosis was associated with significantly higher successful outcome (adjusted OR 3.35, 95% CI, 1.06-10.54, p=0.039) and lower mortality at 12 weeks (adjusted OR 0.20, 0.05-0.78, p=0.021). Conclusions: Lung transplant recipients with nodular lesions due to invasive aspergillosis had better outcomes than those without such lesions.
AB - Background: Whether nodular lesions have specific risk-factors or influence outcomes in lung transplant recipients with invasive aspergillosis, is not fully known. Methods: The study population consisted of 64 consecutive lung transplant recipients with proven or probable invasive aspergillosis. Nodules, with or without halo/air crescent-sign were considered nodular presentations. Outcomes assessed were response rate (successful versus unsuccessful outcome) and all-cause mortality at 12 weeks. Results: Overall, 34 patients had nodular and 30 had non-nodular lesions. Presence of nodular lesions was less likely to be associated with renal failure at baseline (adjusted OR 0.21, 95% CI, 0.04-0.97, p=0.047), CMV infection (adjusted OR 0.18, 95% CI 0.04-0.75, p=0.019) and receipt of antifungal prophylaxis (adjusted OR 0.22, 95% CI, 0.06-0.88, p=0.032). Successful outcome and mortality rates in the study patients were 64.0% (41/64) and 25.0% (16/64), respectively. Nodular aspergillosis was associated with significantly higher successful outcome (adjusted OR 3.35, 95% CI, 1.06-10.54, p=0.039) and lower mortality at 12 weeks (adjusted OR 0.20, 0.05-0.78, p=0.021). Conclusions: Lung transplant recipients with nodular lesions due to invasive aspergillosis had better outcomes than those without such lesions.
KW - Aspergillosis
KW - Lung nodules
KW - Lung transplant
KW - Transplant
UR - http://www.scopus.com/inward/record.url?scp=84878367679&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878367679&partnerID=8YFLogxK
U2 - 10.1016/j.jinf.2013.03.013
DO - 10.1016/j.jinf.2013.03.013
M3 - Article
C2 - 23567625
AN - SCOPUS:84878367679
SN - 0163-4453
VL - 67
SP - 72
EP - 78
JO - Journal of Infection
JF - Journal of Infection
IS - 1
ER -